Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palmitoylethanolamide for treatment of mania in bipolar disorder
IRCT20090117001556N135Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of palmitoylethanolamide in bipolar disorder (BD), sponsored by Tehran University of Medical Sciences. Started May 2021; status: completed.
02
Drugs
palmitoylethanolamide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20090117001556N135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N135.